跳至主要内容
临床试验/JPRN-UMIN000040829
JPRN-UMIN000040829已完成未知

Questionnaire survey on participation in treatment for general consumers - Questionnaire survey on participation in treatment

Santen Pharmaceutical Co., Ltd.0 个研究点目标入组 108 人开始时间: 2020年6月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
108

研究概览

简要总结

More than 70 percent of the subjects answered that they would like to be involved in drug selection when they are diagnosed with glaucoma for the first time and decide on a treatment, and they indicated higher treatment compliance and intention to continue hospital visits when they involved in drug selection. From these facts, it is considered desirable for patients to be involved in the drug selection in in order to improving adherence.

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
40years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Those who previously diagnosed with glaucoma Those who have relatives diagnosed with glaucoma Medical professionals (doctors, pharmacists, nurses, etc.) Those engaged in the manufacturing of pharmaceuticals and medical products Person engaged in drug marketing

研究者

相似试验